EmailFacebookXLinkedIn

Oral abstract session: Modern diagnostics and therapeutic areas

2018-08-07T14:19:00+02:00

Chairs: Meredith Giuliani (CA), Fabio Gomes (GB)14:00-14:12 - O13: Community and academic oncologists' perceptions of the barriers to clinical trial enrolment of older adults with cancer: a qualitative analysis - Mina Sedrak (US)14:12-14:15 - Discussion and questions14:15-14:27 - O14: Incidence of immune related adverse events in patients 70 years old treated with anti-PD-(L)1 therapy - Capucine Baldini (FR)14:27-14:30 - Discussion and questions14:30-14:42 - O15: Outcome and prognostic factors for elderly patients undergoing radiosurgery for brain metastases - Isaaco Desideri (IT)14:42-14:45 - Discussion and questions14:45-14:57 - O16: Breast cancer-associated mutations in older women with triple negative breast cancer (TNBC) - Yanin Chavarri-Guerra (MX)14:57-15:00 - Discussion and questions

Oral abstract session: Modern diagnostics and therapeutic areas2018-08-07T14:19:00+02:00

Oral abstract session: Solid tumours and basic science

2018-08-07T13:49:00+02:00

Chairs: Martine Extermann (US), Barbara Van Leeuwen (NL)11:30-11:42 - O07: An international comparison of treatment strategy and outcomes of older patients with early stage breast cancer treated in an oncogeriatric care and a standard care setting (preliminary results) - Anna de Boer (NL)11:42-11:45 - Discussion and questions11:45-11:57 - O08: Improved quality of life over time after colorectal cancer surgery in functionally dependent older patients - a longitudinal follow-up study - SIOG Young Investigator Award finalist - Daniël Souwer (NL)11:57-12:00 - Discussion and questions12:00-12:12 - O09: Muscle density not mass predicts for survival in older adults with newly diagnosed epithelial ovarian cancer - SIOG Young Investigator Award finalist - Lucy Dumas (UK)12:12-12:15 - Discussion and questions12:15-12:27 - O10: A new treatment option for locally advanced HNSCC in elderly patients: NBTXR3 - Caroline Hoffmann (FR)12:27-12:30 - Discussion and questions12:30-12:42 - O11: Clinically important grade 2 and grade 3+ toxicity during treatment of metastatic [...]

Oral abstract session: Solid tumours and basic science2018-08-07T13:49:00+02:00

Interaction between cognitive impairment and cancer treatment

2018-08-07T13:29:00+02:00

Chairs: Anita O'Donovan (IE), Frederiek van den Bos (NL) 09:30-09:50 - Decision making with pre-existing cognitive dysfunction - Beatriz Korc-Grodzicki (US)09:50-10:10 - Impact of cancer treatment on cognitive function - Lissandra Dal Lago (BE) 10:10-10:30 - Impact of complex symptomatic treatments on cognitive function - Matthieu Frasca (FR)10:30-10:50 - Objective and subjective cognitive performance evaluation (tools) / how to assess cognitive impairment in daily practice - Cindy Borghgraef (BE)10:50-11:00 - Discussion and questions

Interaction between cognitive impairment and cancer treatment2018-08-07T13:29:00+02:00

Plenary session: Geriatric oncology: Hot topics

2018-08-07T13:23:10+02:00

Chairs: Stuart Lichtman (US), Johanna Portielje (NL)08:30-08:45 - Geriatric management and outcome - Marije Hamaker (NL)08:45-09:00 - Immunotherapy in the elderly - management of toxicities - Ellen Kapiteijn (NL)09:00-09:15 - Update in palliative care - Sébastien Moine (FR)09:15-09:30 - Discussion and questions

Plenary session: Geriatric oncology: Hot topics2018-08-07T13:23:10+02:00

Oral abstract session: Supportive and palliative care

2018-08-07T12:21:00+02:00

Chairs: Nienke de Glas (NL), Trine Jørgensen (DK)16:15-16:27 - O01: Accelerated sarcopenia in older adults with a cancer diagnosis - results from the Health ABC study - SIOG Young Investigator Award finalist - Grant Williams (US)16:27-16:30 - Discussions and questions16:30 -16:42 - O02: General practitioners' involvement in oncogeriatric supportive care in France: results of a web survey performed in the area of Lyon city - Marie Valero (FR)16:42 -16:45 - Discussion and questions16:45-16:57 - O03: The independent ability of an older surgical patient to complete an electronic patient reported outcome (EPRO) predicts one year postoperative mortality - Armin Shahrokni (US)16:57 -17:00 - Discussion and questions17:00-17:12 - O04: Polypharmacy, potential inappropriate medications, and drug interactions in older patients with ovarian cancer - influence on treatment completion and prognosis - Trine Jørgensen (DK)17:12-17:15 - Discussion and questions17:15 -17:27 - O05: The fall-prevention intervention 'stepping on: cancer edition' increases fall-preventing behaviors in older [...]

Oral abstract session: Supportive and palliative care2018-08-07T12:21:00+02:00

Industry sponsored satellite session – Day 1

2018-08-07T12:19:00+02:00

The following industry sponsored satellite session is being organized by Sanofi Genzyme. 14:45-15:45 Improving the management of senior adults with prostate cancerChairs: Jean-Pierre Droz (FR), Nicolas Mottet (FR)14:45-15:00 Management of prostate cancer - what's new? - Nicolas Mottet (FR)15:00-15:15 Metastatic prostate cancer in senior adults - a closer look to daily practice - Amit Bahl (GB)15:15-15:30 Updated SIOG guidelines for the management of senior adults with prostate cancer - Jean-Pierre Droz (FR)15:30-15:45 Discussion and questions 

Industry sponsored satellite session – Day 12018-08-07T12:19:00+02:00

Case-based session: Geriatric survivorship issues & management

2018-08-07T12:15:00+02:00

Chairs: William Dale (US), Cornelia Van Zuylen (NL)13:30-13:40 - Functional and physical decline - Melissa Loh (US) 13:40-13:50 - Discussions and questions13:50-14:00 - Elderly cancer patient-centred home care: focus on inappropriate drugs - Pietro Gareri (IT)14:00-14:10 - Discussions and questions14:10-14:20 - Survival management - William Dale (US)14:20-14:30 - Discussions and questions

Case-based session: Geriatric survivorship issues & management2018-08-07T12:15:00+02:00

Localised tumours in vulnerable older adults: choosing the best treatment

2018-08-02T15:41:00+02:00

Chairs: Havaleh Gagne (CA), Julien Garnon (FR)10:30-10:45 - EURECCA comparison of treatment differences of older cancer patients in Europe - Johanna Portielje (NL)10:45-11:00 - Breast cancer - Vasco Fonseca (PT)11:00-11:15 - Bladder cancer - Shaista Hafeez (GB)11:15-11:30 - Glioblastoma cancer - Ana Pais (PT)11:30-11:45 - Non-melanoma skin cancer - Charles Kelly (GB)11:45-12:00 - Discussion and questions

Localised tumours in vulnerable older adults: choosing the best treatment2018-08-02T15:41:00+02:00

Plenary session: Advancements in the field of geriatric oncology

2018-08-02T15:35:00+02:00

Chairs: Marije Hamaker (NL), Pierre Soubeyran (FR) 09:00-09:12 - Update on the selection process of patients - Nienke de Glas (NL)09:12-09:24 - Updates in geriatrics - Frederiek van den Bos (NL)09:24-09:36 - Update in surgery - prediction of early morbidity and mortality - Ponnandai Somasundar (USA)09:36-09:48 - Update in intervention in radiology - Julien Garnon (FR)09:48-10:00 - Discussion and questions

Plenary session: Advancements in the field of geriatric oncology2018-08-02T15:35:00+02:00

Stay in touch and share our news!

SIOG Head Office

  • International Society of Geriatric Oncology
    P/A Comptabilis
    9 route des Jeunes
    1227 Les Acacias - Switzerland

  • +41 22 734 73 43
  • enquiry@siog.org

ECOSOC Special

In Special Consultative Status with the United Nations Economic and Social Council (ECOSOC).

Quick links

 

Stay in the loop with SIOG’s newsletter!

Subscribe now

Powered by K.I.T. Group – Crafted for Excellence

Go to Top